CLINICAL TRIALS PROFILE FOR LORELCO
✉ Email this page to a colleague
All Clinical Trials for LORELCO
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01000467 ↗ | Pharmacokinetics Study for Probucol | Completed | Korea Otsuka Pharmaceutical Co., Ltd. | Phase 4 | 2009-02-01 | To evaluate the safety and pharmacokinetics of probucol by multiple oral administration in healthy male subjects. |
NCT01349010 ↗ | Efficacy and Safety of Imported Probucol to Treat Hyperlipidemia | Completed | Otsuka Beijing Research Institute | Phase 3 | 2011-04-01 | The purpose of this study is to evaluate the efficacy and safety of imported Probucol in hyperlipidemia patients. |
NCT01590901 ↗ | Pharmacokinetics and Safety Study of Probucol by Multiple Administration in Healthy Male Subjects | Completed | Otsuka Beijing Research Institute | Phase 1 | 2012-02-01 | The Objectives of this study is to evaluate the pharmacokinetics and safety of multiple oral doses of probucol in healthy male subjects. |
NCT02196805 ↗ | A Bioequivalence Study Comparing a Single Oral Intake of an Imported PROBUCOL Tablet(Lorelco) With a Marketed PROBUCOL Tablet(Chang Tai) in Chinese Healthy Volunteers | Completed | Otsuka Beijing Research Institute | N/A | 2009-03-01 | This study compares the pharmacokinetics characteristics of a single oral intake of an imported PROBUCOL tablet(Lorelco)(1*250mg/tablet) with a marketed PROBUCOL tablet (Chang Tai)(1*250mg/tablet) in healthy male volunteers to demonstrate they are bioequivalent. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for LORELCO
Condition Name
Clinical Trial Locations for LORELCO
Clinical Trial Progress for LORELCO
Clinical Trial Phase
Clinical Trial Sponsors for LORELCO
Sponsor Name